- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: ACA Replacement Legislation Coming Monday
What we're reading, January 18, 2017: GOP senators plan to reveal Obamacare replacement next week; McKesson to pay $150 million to settle claims that it didn't report suspicious opioid orders; and Sylvia Mathews Burwell will go on DC health insurance exchange once she leaves her post.
A plan to replace the Affordable Care Act (ACA) will be introduced on Monday by Senators Susan Collins (R-Maine) and Bill Cassidy (R-Louisiana). According to The Hill, the plan is based on a 2015 proposal and provides states with the flexibility to keep the ACA or choose another path with funding earmarked for the ACA. Full details have not been released yet, but Cassiday said the plan could cover up to 95% of Americans. Senator Rand Paul (R-Kentucky) may also introduce his own alternative replacement plan.
McKesson has agreed to pay $150 million in a settlement over whether it failed to report suspicious opioid orders. The deal follows a similar settlement with McKesson over violations in 2008, according to Reuters, plus comes just days after Cardinal Health agreed to pay $44 million for not alerting the Drug Enforcement Administration of suspicious orders. McKesson will suspend sales of controlled substances from centers in Colorado, Florida, Michigan, and Ohio for several years.
Once Sylvia Mathews Burwell leaves her position as HHS secretary when the new administration comes in, she plans to go onto the ACA exchange in DC. Burwell is currently on the federal employee plan, but once she is no longer covered by that plan, she will enter the exchange despite GOP plans to repeal the ACA, reported POLITICO. She added that with her husband having a preexisting condition, getting coverage before the health law was passed would not have been possible. Burwell has led the implementation of the ACA for the last 2 years.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
